Skip to content
Open access · OA via OpenAlex

<i>C. elegans</i> as Model for the Study of High Glucose– Mediated Life Span Reduction

Andreas Schlotterer, G Kukudov, Farastuk Bozorgmehr, Harald Hutter, Xueliang Du, Dimitrios Oikonomou, Youssef Ibrahim, Friederike Pfisterer, Naila Rabbani, Paul J. Thornalley, Ahmed M. Sayed, Thomas Fleming, Per M. Humpert, Vedat Schwenger, Martin Zeier

Diabetes · 2009 · ▲ 296 citations

Abstract

OBJECTIVE: Establishing Caenorhabditis elegans as a model for glucose toxicity-mediated life span reduction. RESEARCH DESIGN AND METHODS: C. elegans were maintained to achieve glucose concentrations resembling the hyperglycemic conditions in diabetic patients. The effects of high glucose on life span, glyoxalase-1 activity, advanced glycation end products (AGEs), and reactive oxygen species (ROS) formation and on mitochondrial function were studied. RESULTS: High glucose conditions reduced mean life span from 18.5 + or - 0.4 to 16.5 + or - 0.6 days and maximum life span from 25.9 + or - 0.4 to 23.2 + or - 0.4 days, independent of glucose effects on cuticle or bacterial metabolization of glucose. The formation of methylglyoxal-modified mitochondrial proteins and ROS was significantly increased by high glucose conditions and reduced by mitochondrial uncoupling and complex IIIQo inhibition. Overexpression of the methylglyoxal-detoxifying enzyme glyoxalase-1 attenuated the life-shortening effect of glucose by reducing AGE accumulation (by 65%) and ROS formation (by 50%) and restored mean (16.5 + or - 0.6 to 20.6 + or - 0.4 days) and maximum life span (23.2 + or - 0.4 to 27.7 + or - 2.3 days). In contrast, inhibition of glyoxalase-1 by RNAi further reduced mean (16.5 + or - 0.6 to 13.9 + or - 0.7 days) and maximum life span (23.2 + or - 0.4 to 20.3 + or - 1.1 days). The life span reduction by glyoxalase-1 inhibition was independent from the insulin signaling pathway because high glucose conditions also affected daf-2 knockdown animals in a similar manner. CONCLUSIONS: C. elegans is a suitable model organism to study glucose toxicity, in which high glucose conditions limit the life span by increasing ROS formation and AGE modification of mitochondrial proteins in a daf-2 independent manner. Most importantly, glucose toxicity can be prevented by improving glyoxalase-1-dependent methylglyoxal detoxification or preventing mitochondrial dysfunction(definition).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.2337/db09-0567
Canonical
link ↗
Fetched
2026-06-30 MST

Cite this

APA
Schlotterer, A., Kukudov, G., Bozorgmehr, F., Hutter, H., Du, X., Oikonomou, D., Ibrahim, Y., Pfisterer, F., Rabbani, N., Thornalley, P.J., Sayed, A.M., Fleming, T., Humpert, P.M., Schwenger, V., Zeier, M., Hamann, A., Stern, D.M., Brownlee, M., Bierhaus, A., &amp; Nawroth, P.P. (2009). <i>C. elegans</i> as Model for the Study of High Glucose– Mediated Life Span Reduction. <em>Diabetes</em>. https://doi.org/10.2337/db09-0567
Vancouver
Schlotterer A, Kukudov G, Bozorgmehr F, Hutter H, Du X, Oikonomou D, et al. <i>C. elegans</i> as Model for the Study of High Glucose– Mediated Life Span Reduction. Diabetes. 2009. doi:10.2337/db09-0567.
BibTeX
@article{andreas2009iCeleg, title = {<i>C. elegans</i> as Model for the Study of High Glucose– Mediated Life Span Reduction}, author = {Andreas Schlotterer and G Kukudov and Farastuk Bozorgmehr and Harald Hutter and Xueliang Du and Dimitrios Oikonomou and Youssef Ibrahim and Friederike Pfisterer and Naila Rabbani and Paul J. Thornalley and Ahmed M. Sayed and Thomas Fleming and Per M. Humpert and Vedat Schwenger and Martin Zeier and A. Hamann and David M. Stern and Michael Brownlee and Angelika Bierhaus and Peter P. Nawroth and Michael Morcos}, journal = {Diabetes}, year = {2009}, doi = {10.2337/db09-0567}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings